Aster Capital Management (Difc) LTD Acadia Pharmaceuticals Inc Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 40,609 shares of ACAD stock, worth $775,631. This represents 0.28% of its overall portfolio holdings.
Number of Shares
40,609Holding current value
$775,631% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
301Shares Held
163MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$819 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$266 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$262 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$230 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$114 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.09B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...